We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
-27.83%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$401M
AUM Growth
-$388M
(-49%)
Cap. Flow
-$199M
Cap. Flow
% of AUM
-49.72%
Top 10 Holdings %
Top 10 Hldgs %
87.59%
Holding
261
New
46
Increased
16
Reduced
19
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PACW
PacWest Bancorp
PACW
|
+$2.51M |
| 2 |
Bank of Hawaii
BOH
|
+$1.95M |
| 3 |
Edwards Lifesciences
EW
|
+$1.89M |
| 4 |
PBCT
People's United Financial Inc
PBCT
|
+$1.86M |
| 5 |
Commerce Bancshares
CBSH
|
+$1.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NE
Noble Corporation
NE
|
+$6.57M |
| 2 |
RPC Inc
RES
|
+$5.85M |
| 3 |
Halliburton
HAL
|
+$5.84M |
| 4 |
RDC
Rowan Companies Plc
RDC
|
+$5.61M |
| 5 |
Exelon
EXC
|
+$5.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.69% |
| 2 | Healthcare | 3.16% |
| 3 | Industrials | 2.43% |
| 4 | Technology | 1.51% |
| 5 | Materials | 0.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JUNO
1
DELISTED
Juno Therapeutics, Inc.
JUNO
| $327M | 81.61% |
17,348,799
| – | – |
|
2
FNB Corp
FNB
$6.73B
| $5.37M | 1.34% |
335,000
+95,000
| +40% | +$1.35M |
|
|
PACW
3
DELISTED
PacWest Bancorp
PACW
| $4.14M | 1.03% |
76,000
+52,000
| +217% | +$2.51M |
|
4
Zimmer Biomet
ZBH
$18.2B
| $2.21M | 0.55% |
22,034
+7,320
| +50% | +$785K |
|
|
CADE
5
DELISTED
Cadence Bank
CADE
| $2.17M | 0.54% |
70,000
+50,000
| +250% | +$1.34M |
|
|
6
Bank of Hawaii
BOH
$3.15B
| $2.13M | 0.53% |
+24,000
| New | +$1.95M |
|
7
Huntington Bancshares
HBAN
$34.4B
| $2.12M | 0.53% |
160,000
-40,000
| -20% | -$466K |
|
|
PBCT
8
DELISTED
People's United Financial Inc
PBCT
| $2.03M | 0.51% |
+105,000
| New | +$1.86M |
|
|
9
Commerce Bancshares
CBSH
$8.53B
| $2M | 0.5% |
+53,754
| New | +$1.81M |
|
|
10
Edwards Lifesciences
EW
$49.6B
| $1.82M | 0.45% |
+58,341
| New | +$1.89M |
|
11
East-West Bancorp
EWBC
$17.9B
| $1.82M | 0.45% |
35,800
+7,800
| +28% | +$347K |
|
12
Regions Financial
RF
$26.4B
| $1.72M | 0.43% |
+120,000
| New | +$1.48M |
|
13
M&T Bank
MTB
$35.7B
| $1.72M | 0.43% |
11,000
+5,000
| +83% | +$677K |
|
14
Biogen
BIIB
$30B
| $1.65M | 0.41% |
5,832
+2,262
| +63% | +$671K |
|
15
Associated Banc-Corp
ASB
$5.83B
| $1.61M | 0.4% |
+65,000
| New | +$1.43M |
|
16
Western Alliance Bancorporation
WAL
$8.79B
| $1.51M | 0.38% |
+31,000
| New | +$1.33M |
|
17
Fulton Financial
FULT
$4.66B
| $1.32M | 0.33% |
70,000
-10,000
| -13% | -$168K |
|
18
Prosperity Bancshares
PB
$8.97B
| $1.29M | 0.32% |
+18,000
| New | +$1.13M |
|
19
Generac Holdings
GNRC
$11.6B
| $1.25M | 0.31% |
+30,623
| New | +$1.21M |
|
20
Truist Financial
TFC
$63.3B
| $1.18M | 0.29% |
+25,000
| New | +$1.06M |
|
21
US Bancorp
USB
$98.2B
| $1.03M | 0.26% |
20,000
+5,000
| +33% | +$238K |
|
|
KTWO
22
DELISTED
K2M Group Holdings, Inc
KTWO
| $991K | 0.25% |
49,468
+19,112
| +63% | +$363K |
|
23
DNOW Inc
DNOW
$2.58B
| $956K | 0.24% |
+46,714
| New | +$990K |
|
|
AXDX
24
DELISTED
Accelerate Diagnostics
AXDX
| $944K | 0.24% |
4,547
+2,047
| +82% | +$486K |
|
|
EFII
25
DELISTED
Electronics for Imaging
EFII
| $929K | 0.23% |
+21,176
| New | +$931K |
|
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q4 2016 Portfolio in Review
As of Q4 2016, Crestline Management held 261 positions worth $401M, down 49% from $789M the previous quarter. Its ten largest holdings account for 88% of the portfolio.
Crestline Management withdrew a net $199M in Q4 2016, closing 179 positions and reducing 19 holdings. Its most notable exit was Noble Corporation, an estimated $6.57M position sold in full.
By sector, the portfolio is most concentrated in Financials at 7.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Crestline Management opened a new position in Bank of Hawaii worth $2.13M.
- Crestline Management's largest Q4 2016 buy was Bank of Hawaii: 24,000 shares worth $2.13M.
- Crestline Management added most to PacWest Bancorp in Q4 2016, an estimated $2.51M increase.
- Crestline Management's biggest Q4 2016 reduction was Crown Castle, cutting an estimated $2.18M.
- Crestline Management fully exited Noble Corporation in Q4 2016, selling an estimated $6.57M.
- Crestline Management's ten largest holdings make up 88% of its $401M portfolio in Q4 2016.
- Crestline Management opened 46 new positions and closed 179 in Q4 2016.
- Crestline Management's portfolio value fell 49% quarter-over-quarter to $401M.
Based on Crestline Management's 13F filing for Q4 2016, filed 14 Feb 2017.